Update on the Spinal Muscular Atrophy Drug Development Pipeline from Families of SMA
Elk Grove Village, IL. January 19, 2012. Developing new therapies to treat and ultimately cure SMA is the driving force behind Families of SMA. To achieve this goal, Families of SMA aggressively invests in drug development research, funding the most successful and innovative scientists and organizations. Several key details demonstrate the great progress being made:1) Programs are advancing into the clinical trial stage of testing.There are now 3 novel programs actively being testing in clinical trials for SMA.2) There is a broad diversity of approaches in development.This